A study to analyze patterns of structural changes in clinically significant diabetic macular edema on Optical coherence tomography. by Shivaraj, Budihal
A STUDY TO ANALYZE PATTERNS OF STRUCTURAL 
CHANGES IN CLINICALLY SIGNIFICANT DIABETIC 
MACULAR EDEMA ON OPTICAL COHERENCE 
Submitted in partial fulfilment of requirements of
M.S. OPHTHALMOLOGY
REGIONAL INSTITUTE OF 
MADRAS MEDICAL COLLEGE
DR.M.G.R. MEDICAL UNIVERSITY
Dissertation on 
TOMOGRAPHY 
 
 
 
BRANCH – III 
OPHTHALMOLOGY
 
CHENNAI- 600 003 
 
 
THE TAMILNADU 
 
CHENNAI 
 
APRIL 2013 
 
2 
 
 CERTIFICATE 
 
This is to certify that this dissertation entitled “A STUDY TO 
ANALYZE PATTERNS OF STRUCTURAL CHANGES IN 
CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA ON 
OPTICAL COHERENCE TOMOGRAPHY” is a bonafide record of the 
research work done by Dr. SHIVARAJ BUDIHAL, Post graduate in 
Regional Institute of Ophthalmology, Madras Medical College and, 
Government General Hospital, Chennai-03, in partial fulfilment of the 
regulations laid down by The Tamil Nadu Dr.M.G.R. Medical University 
for the award of M.S. Ophthalmology Branch III, under my guidance and 
supervision during the academic years 2010-2013.  
 
 
 
 
Prof. Dr. R.ravikumar, M.S, D.O 
Chief, uvea and retina services 
Regional Institute of Ophthalmology 
Govt ophthalmic hospital 
Chennai - 600008 
Prof. Dr. K. MARAGATHAM,  M.S    
 Director and Superintendent I/C  
 Regional Institute of Ophthalmology 
Govt ophthalmic hospital 
Chennai - 600008 
 
 
 
Prof. Dr. V.KANAGASABAI,M.D.,Ph.D 
Dean 
Madras Medical College 
Chennai – 600 003 
  
 
                                                               
3 
 
ACKNOWLEDGEMENT 
 
I express my sincere thanks and gratitude to                               
Prof. DR. V. KANAGASABAI, M.D., Dean, Madras Medical College for 
permitting me to conduct this study.  
 
I have great pleasure in thanking professor Dr. K. MARAGATHAM, 
M.S., DO., Director and Superintendent RIO – GOH, Madras Medical 
College, Chennai, for her valuable advice in preparing this dissertation.  
 
I express my profound gratitude to Prof . Dr. R. RAVIKUMAR 
M.S., D.O., my unit chief and my guide for his valuable guidance and 
constant support at every stage throughout the period of this study.  
 
I am very grateful to my unit assistants,Prof B.RADHAKRISHNAN 
M.S., D.O., Dr. A. PALANIRAJ M.S., Dr. R. PADMAPRIYA M.S., and 
Dr. K.RAVIKUMAR, M.S.,for rendering their valuable advice and 
guidance for the study.  
 
I wish to express my sincere thanks to all the professors, assistant 
professors and all my colleagues who had helped me in bringing out this 
study.  
 
Finally, I am indebted to all the patients for their sincere co-operation 
for the completion of this study. 
 
 
 
4 
 
  
5 
 
 
 
6 
 
7 
 
DECLARATION BY THE CANDIDATE 
 
I hereby declare that this dissertation titled “A STUDY TO 
ANALYZE PATTERNS OF STRUCTURAL CHANGES IN 
CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA ON 
OPTICAL COHERENCE TOMOGRAPHY” is a bonfide and genuine 
research work carried out by me under the guidance of Prof. Dr, R . 
Ravikumar M.S.,D.O, Professor Department of Uvea and Retina services , 
Regional institiute of ophthalmology. Government Ophthalmic hospital. 
Chennai -600008. 
 
Date 
Place 
 
Dr. SHIVARAJ BUDIHAL, 
 
8 
 
CONTENTS 
 
S.NO. TITLE PAGE NO 
 PART -1  
1. INTRODUCTION TO OPTICAL COHERENCE 
TOMOGRAPHY 
1 
2. OPTICAL COHERENCE TOMOGRAPHY PRINCIPLE 
AND INTERPRETATION  
4 
3. SCAN PROTOCOLS FOR MACULA  17 
4. RECENT ADVANCEMENTS IN OPTICAL 
COHERENCE TOMOGRAPHY 
21 
5. COMPARISON OF OPTICAL COHERENCE 
TOMOGRAPHY WITH OTHER TECHNIQUES OF 
RETINAL IMAGING  
23 
6. COMPARISON OF OPTICAL COHERENCE 
TOMOGRAPHY WITH OTHER IMAGING 
MODALITIES  
24 
7. INTRODUCTION TO DIABETIC MACULAR EDEMA  26 
8. ANATOMY OF RETINA   28 
9. RISK FACTORS AND CLINICAL ASSOCIATIONS  37 
10. PATHOPHYSIOLOGY  40 
11. CLASSIFICATION  43 
12. OPTICAL COHERENCE TOMOGRAPHY IN 
DIABETIC MACULAR EDEMA 
49 
13. MANAGEMENT  55 
 PART II  
14. AIM OF THE STUDY  59 
15. MATERIALS AND METHODS 60 
16. OBSERVATION AND ANALYSIS 62 
17. DISCUSSION 80 
18. CONCLUSION  85 
 PART III  
19. BIBLIOGRAPHY   
20. PROFORMA  
21. MASTER CHART   
22. KEY TO MASTER CHART  
 
9 
 
ABBREVIATIONS 
 
OCT  - Optical coherence tomography 
FFA  - Fundus fluorescein angiography 
DR  - Diabetic retinopathy 
NPDR - Non proliferative diabetic retinopathy 
PDR  - Proliferative diabetic retinopathy 
WESDR - Wisconsin Epidemiologic Study of Diabetic   retinopathy    
ETDRS - The Early Treatment Diabetic Retinopathy study 
VEGF - Vascular endothelial growth factor 
CSME - Clinically significant macular edema 
CME  - Cystoid macular edema 
SRD  - Serous retinal detachment 
VMT  - Vitreomacular traction 
TPH  - Taut posterior hyaloids 
 
 
 
10 
 
INTRODUCTION TO OPTICAL COHERENCE 
TOMOGRAPHY 
 
A variety of imaging modalities have been utilized to assess the 
retinal pathology. Among the frequently used imaging modalities include 
the fundus photography, fundus fluorescein angiography, indocyanine green 
angiography and ultrasonography. However detailed information about the 
retinal microstructure and quantitative retinal thickness are not obtained by 
these  techniques
1.
 
 
Thus there existed a need for a technology which could perform 
optical biopsy, image at or near the resolution of histopathology without 
performing an excisional biopsy
2
. Recent advances in fibre optics and 
technological advancements in laser have provided us with a non contact, 
high resolution optical biomedical imaging technology called optical 
coherence  tomography
3
. 
 
Optical coherence tomography was first invented in 1990 at 
Massachusetts institute of Technology in boston. First in vivo image of 
human retina was obtained in 1993 and the first clinical retinal images were 
obtained in 1995.Optical coherence tomography has become a revolutionary 
biomedical tissue imaging technique providing a high resolution cross 
11 
 
sectional visualization of retinal structure and other tissues which require 
micrometer  resolution  and  millimetre  depth perception
4
.
 
 
Low coherence interferometry5 a classical optical measurement 
technique along with near broad band light is used by OCT to provide high 
resolution cross sectional visualization of tissue morphological structure at 
depth significantly greater than penetrating depth offered by confocal 
microscopy and conventional bright - field. OCT is analogous to ultrasound 
imaging, except that it uses light instead of sound.  
 
Presently OCT is being utilized in 3 different fields of optical 
imaging. First is in macroscopic imaging of structures which can be 
visualised by the naked eye or with the help of weak magnifications.    
Secondly is in microscopic imaging using magnifications upto the limit of 
microscopic resolution. Thirdly in endoscopic imaging, using medium  and 
low magnification
6
. 
 
Commercially available optical coherence tomography systems are 
being used for   diverse applications. Few of the areas include in diagnostic 
medicine notably in ophthalmology where it is being used for obtaining high 
resolution cross sectional images of anterior segment of the eye and retina. 
Interventional cardiology is another area where it is being used to help 
12 
 
diagnose coronary artery disease7. In combination with catheters and 
endoscopes enables high-resolution intraluminal imaging of organ systems. 
 
OCT is also being used in non medical fields like in conservation of 
paintings and in variety of industrial applications like non destructive 
testing, material thickness measurements and in silicon and semiconductor 
wafer thickness measurements8. 
 
OCT offers several advantages over the other imaging techniques  
• Non  contact and  non-invasive. 
• Easily tolerated by patients especially the children. 
• Changes in macular thickness over time can be assessed. 
• Uses safe non ionising radiation. 
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BASIC PRINCIPLE OF OPTICAL COHERENCE 
TOMOGRAPHY 
 
OCT is a non contact, non invasive device based on the principle of 
Michelson interferometry
9
. Broad band with near infrared beam (820nm) 
coupled to a fiber optic is projected  to a beam splitter and reaches the retina 
and  a reference mirror respectively after passing through the ocular 
media
10
. Boundaries between the retinal microstructures reflect this light 
and also the light is scattered differently by tissues with different optical 
properties. 
 
Time delay between light reflected by different layers of retina is 
compared with time delay of light reflected from reference mirror at a 
known distance. These reflected pulses from the retina and reference mirror 
are combined by the interferometer to produce a phenomenon called 
interference
11
. 
 
Photodetector measures the interference. The distance travelled by 
various light pulses is determined by varying distance to the reference 
mirror. This produces a range of time delay which is compared. The 
interferometer constructs a tomogram of retinal structure by integrating 
several data points over a 2 mm depth which is in real time and represented 
14 
 
using a false colour scale. Degree of light backscattering is represented by 
different colours. 
 
Thus the OCT image generated has a 10mm axial resolution and 
20mm transverse resolution. A scans are aligned using digital processing to 
correct for eye motion. Signal- to- noise ratio is further improved using 
digital smoothing techniques12. 
 
Image display 
Retinal image can be acquired by using the OCT even in the absence 
of pupillary dilation. A 3mm pupil is sufficient for adequate visualization. 
Retina is focused by adjusting the imaging lens placed at a distance of 1 cm 
from the eye. Position of the scanning beam over the retina is documented 
by an infrared- sensitive charge coupled device video camera.  
 
Scan image can be displayed in two forms in an OCT. One is on grey 
scale where more reflected light appears brighter than less reflected light. 
Other is using a colour scale where different degrees of reflectivity are 
represented by different colours. Highly reflective layers appear in bright 
colours (white and red) and darker colour represents lowly reflective layers 
(black and blue). Green represents intermediate reflectivity
13
. 
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Fig 1   OPTICAL COHERENCE TOMOGRAPHY 
 
 
Fig2  PRINCIPLE OF OCT 
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NORMAL OCT SCAN 
OCT allows retina to be studied from vitreous to choriocapillaries and 
superficial choroidal layers in terms of cross section. Two major structural 
landmarks seen on a normal horizontal 10 mm scan include the optic disc 
and fovea. 
 
Optic disc is easily identifiable by its contour on the right side of the 
tomogram. Optic nerve head cup is seen as a central depression and anterior 
part of optic nerve is represented by stalk continuing behind the central 
depression. The characteristic thinning of the retinal nerve fibre layer on the 
left of the tomogram helps in identifying the fovea. 
 
Dark space anterior to retina represents the vitreous which is not 
reflective. Vitreo-retinal interface is the interface between non reflective 
vitreous and the first backscattering retinal layer
14
. The posterior hyaloid is 
visible as a faint and slightly reflective line which may be in contact with 
retina or detached. 
 
The retinal nerve fibre layer is thicker on nasal side due to density of 
papillomacular bundle and is a highly reflective layer. A second hyper-
reflective layer is retinal pigment epithelium - choriocapillaries complex 
which marks the posterior boundary of the retina.  
 
17 
 
The photoreceptor layer is a minimally reflective layer lying just 
anterior to RPE -choriocapillaries complex and its poor reflectivity is due to 
vertical orientation of the photoreceptors
15
. This area is thick in areas of 
foveal depression. Alternating layers of moderate and low reflectivity lie 
anterior to layer of photoreceptors representing different layers of 
neurosensory retina. Plexiform layer are more reflective than nuclear layers.     
Retinal blood vessels show backscattering. 
 
Different layers of retina have different reflectivity pattern and are   
represented by different colours in false colour map- 
a. Highly reflective  layers  are the   retinal  nerve   fibre    layer and 
RPE- choriocapillaries complex represented by dark colour.  
b. Nuclear layers are hypo-reflective. 
c. Plexiform layers are hyper-reflective compared to nuclear layer. 
d. Another hyper-reflective structure is the choroid but frequently not 
well resolved because reflection of light by overlying RPE. 
Thus the structures oriented vertically in retina have lesser reflectivity 
and the  structures oriented horizontally have higher reflectivity. 
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INTERPRETATION  OF  THE OPTICAL   COHERENCE 
TOMOGRAPHY 
There are two modes of interpreting an OCT image i.e objective and 
subjective. Combination of both of these modes is necessary for accurate 
interpretation of the OCT image
16
. 
 
Retinal abnormalities are detected by OCT in terms of thickness, 
morphology  and  reflectivity. 
 
OCT must be read in two stages 
1. Qualitative  and  quantitative  analysis  
2. Deduction and synthesis 
 
The analysis study can be further classified into   
QUALITATIVE ANALYSIS 
1. Morphological study 
Variations in morphology - structural changes in overall retina,  
retinal  outline changes, structural changes within the retina and posterior 
layers. 
 
2. Reflectivity study 
Includes shadow areas, hypo-reflectivity and hyper-reflectivity 
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QUANTITATIVE ANALYSIS 
This includes surface mapping, retinal volume and thickness. All the 
analytical data, results of clinical examination and all the other available 
data are compared in deductive and synthetic study. 
 
Protocols are available for both qualitative and quantitative estimation 
in the OCT software. 
 
QUALITATIVE ANALYSIS   
several image modification protocols are available for qualitative 
analysis 
1. Normalize- 
The background noise is eliminated using this protocol and the signal 
strength is improved. Using this protocol scan images are normalized with 
respect to noise and signal strength.  After application of this protocol to 
scan images made with different noise or signal strength, the images appear 
"bright" equally. All of the resulting images have the same range of colour. 
 
2. Align 
The errors resulting from movements of the patient in axial direction 
are corrected using this protocol. Head movement’s toward or away from 
the OCT machine results in vertical shifting of the scan image resulting in 
low frequency “wiggles”. This is corrected by the protocol by comparing 
20 
 
each of   longitudinal A- scans in data set with its neighbour. This process is 
called correlation. Data are aligned by sliding A-scan 1 in relation to A-scan 
1 till they align. Then A-scan 3 is aligned with A- scan 2 and this process is 
repeated till all A scans are aligned thus negating the errors due to the 
movement of the patients head.  
 
3. Normalize with align  
This protocol performs both the above function.  
 
4. Gaussian and median smoothing 
These protocols balance the background noise and blend the colours 
of the scan images. By using these protocols the large scale features in data 
are better appreciated. 
 
Gaussian smoothing calculates a moving average of signal values in 
3x3 regions. Gaussian function is used to weigh the signal values. The outer 
points are weighed less compared to the centre point and there by average 
are calculated. 
 
Similar to Gaussian smoothing is the median smoothing. Difference 
being the median smoothing utilizes the median value of the 3x3 region 
unlike the gaussian smoothing which uses the moving average.  Median 
smoothing has the advantage of preserving small details in data which are 
lost in Gaussian smoothing. 
21 
 
 
5. Proportional 
This protocol provides an image that is true in its horizontal and 
vertical proportions. Usually the scan image is elongated vertically allowing 
complete visualization of longitudinal plane. After using this protocol the 
image produced is compressed vertically. 
 
6. Scan profile 
The signal values for all data points are provided by this protocol. The 
graph changes dynamically on moving the cursor over the OCT image. 
These image processing protocols can be used prior to objective assessment 
of the OCT scan image. These protocols apply mathematical algorithms for 
giving the visual analysis . 
 
MORPHOLOGICAL STUDY 
Deformation of retina 
A) Concavity: 
In certain conditions the OCT may show the presence of pronounced 
concavity as in posterior staphyloma and high myopia. However processing 
the scan image using the alignment function may make the concavity less 
pronounced. 
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B) Convexity: 
Sub retinal cysts and retinal pigment epithelial detachment produce 
convexity which can be accurately detected by performing on OCT imaging. 
 
DEFORMATION OF THR RETINAL PROFILE 
a. Disappearance of foveal depression 
Foveal depression can be lost in retinal condition such as macular 
edema   sub-foveal retinal detachment and other pathologies.  This 
alteration n foveal contour can be accurately identified by OCT 
imaging technique. Assessing the foveal contour also helps in 
predicting the response to the treatment. 
 
b. Epiretinal membrane 
Can have various presentations, either adherent or separate from the 
retina. Folds may be visible on the retinal surface. 
 
c. Macular pseudo hole or lamellar macular hole   
 
d. Macular holes  
OCT plays a important role in diagnosing and staging of macular hole. 
Diameter and extent of the detachment can be assessed by using OCT 
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INTRARETINAL STRUCTURAL CHANGES  
a. Cysts in cystoid macular edema appear as hypo reflective spaces of 
varying size. These are mainly confined to the outer retinal layers. 
Fusion of these spaces can occur in chronic cases leading to formation 
of very large cystic spaces occupying the full thickness of retinal 
layers. 
b. Pseudoholes 
c. Hard exudates are hyper-reflective shadows at the margin of the 
edematous and normal retina and block the reflections from the 
underlying retina. 
d. Cotton wool spots are hyper-reflective retinal nodules in nerve fibre 
layer are present at margins of ischemic lesions of NFL.  
 
POSTERIOR MORPHOLOGICAL CHANGES 
a. Retinal pigment epithelial detachment produce deformation of posterior 
retina on OCT scan. These form a steep angle with the 
choriocapillaries. 
b. Serous retinal detachment of form shallow angles with RPE 
c. Drusens are seen as irregularities and wavy undulation of the RPE   and 
choriocapillaries. 
24 
 
d. Choroidal neovascular membrane appears as nodular rounded fusiform 
structures anterior to RPE. Edema and serous retinal detachment may 
be present. Occult neovascular membranes are difficult to detect. 
 
REFLECTIVE STUDY  
An OCT scan may show areas of increased or decreased reflectivity 
or shadow areas whenever retinal pathology is present. 
 
Shadow areas  
          A OCT scan shows a shadow area when a area of dense, hyper-
reflective tissue is present producing a screen which may be complete or 
incomplete. Elements lying behind the shadow area are concealed.  
 
Anterior shadow and screen effects are seen in  
Normal - Retinal blood vessels  
Abnormal - Hemorrhage 
- Exudates 
 
Posterior shadow and screen effects are seen in  
- Pigment epithelial hypertrophy/hyperplasia  
- Accumulation of pigment 
- Retinal scars 
- Choroidal  nevi 
25 
 
QUANTITATIVE ANALYSIS  
a) Retinal thickness/ volume 
Thickness and volume of the retina are obtained by using this 
protocol in the form of two circular maps one for each eye. 
 
b) Retinal thickness/volume tabular 
This protocol in addition to providing retinal thickness and volume 
also provides a table that displaying average thickness and volume of retina 
in each quadrant, ratios and differences between the quadrants and between 
the 2  eyes. 
 
c) Retinal thickness/volume change  
Retina thickness /volume changes in between examinations can be 
assessed using this protocol. 
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OCT SCAN PROTOCOLS 
various scan acquisition protocols are offered but the Stratus OCT 3. 
Appropriate protocols have to be used to get most accurate information. 
 
OCT SCAN PROTOCOLS FOR IMAGING MACULA 
1. Line  scan  
2. Radial scan 
3. Macular thickness map 
4. Fast macular thickness map  
5. Raster lines 
6. Repeat scan 
 
ANALYSIS PROTOCOLS 
1. Retinal thickness 
2. Retinal map 
3. Retinal thickness/volume 
 
Line scan   
Using this protocol multiple line scans can be acquired without the 
need of returning to the main window. Default angle being 0
0
. Nasal 
position is taken as 0
0
. It is possible to alter the length and angle of the line 
scan with 5 mm being the default length of line scan. Resolution of scan 
27 
 
image is inversely proportional to the length of the line scan. Protocol also 
helps in acquiring multiple scans of different parameters . 
 
Radial scan  
This protocol is a combination of 6 to 24 line scan which pass 
through a central common axis and are equally spaced. Size and parameters 
can be varied .Default setting consists of 6 lines each of which measure 6 
mm in length. By adjusting the size of the aiming circle the length of these 
line scans is altered. However this change has to be made before saving the 
first scan. Macular scan and retinal thickness/volume analysis can be 
acquired using radial scans. 
 
Macular thickness map 
Similar to radial lines with only difference being that the aiming 
circle has a fixed diameter of 6mm.useful for retinal thickness measurement. 
 
Fast macular thickness  map 
This protocol acquires 6 scans each of 6 mm length quickly i.e within 
1.92 second .It is not possible to alter the size and number of scans in this 
protocol. This protocol is used with retinal thickness analysis and by 
performing in both the eyes retinal thickness and volume can be compared 
between the two eyes. 
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Raster lines  
Using this protocol about 6 -24 line scans are obtained which are 
parallel and spaced equally. These line scans are acquired over a rectangular 
area. Size of this area can be altered to include the entire area of pathology. 
This protocol is useful when one wishes to acquire scan at multiple levels as 
in choroidal neovascular membrane. Default area is a 3mm square 
consisting of 6 lines which are acquired from superior to inferior followed 
by nasal to temporal. 
 
Repeat 
Using this protocol it is possible to repeat any of the previously saved 
protocols which utilize the same parameters like size, angle, placement of 
fixation and landmark. It is not possible to change any of the parameters 
except for the placement. Landmark is placed on reference point helping in 
reproducibility during repeat scan. Landmark can be placed accurately by 
looking at the previous image which can be displayed on the screen. 
 
OCT AND SCANNING LASER OPHTALMOSCOPE 
TECHNOLOGY 
Two specific limitations of OCT include 
1. Errors in A - scan image correlation and interpolation- The image 
quality becomes less reliable due to increase in correlation and interpolation 
errors of A-scan as the scan length increase from 3 to 10 mm. 
29 
 
 
2. Precise anatomic localization of the OCT image from the red free 
image - The red free image showing the position of OCT is not pixel linked.  
Because of this the precise anatomic localization is compromised. A newer 
device is being developed which provides precise OCT image localization. 
It creates OCT B- scan image and uses simultaneous red free scanning laser 
ophthalmoscope to achieve this. Horizontal scanning is performed in 
ophthalmoscopic plane at increasing depths to create OCT B -scan images. 
C scan image is produced by accumulating information from entire plane of 
tissue at varying depths. 3-D OCT images can be constructed by processing 
numerous C scan images allowing for linear and volumetric measurements. 
 
This device utilizes a beam splitter at the light source to produce two 
channels. Conventional SLO is used by one channel to produce red free 
image by one channel. Other channel is used to produce simultaneous OCT 
images and precise anatomic localization is possible since these images are 
pixel linked. Hence this device provides better resolution and image 
localization than conventional OCT. 
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RECENT TECHNOLOGICAL ADVANCEMENTS IN OCT    
TECHNOLOGY 
a) ULTRA HIGH RESOLUTION OCT 
A recent improvement in OCT technology is ultra high resolution 
OCT
17 
that allows for unprecedented in vivo sub cellular and intraretinal 
visualization. UHR OCT provides a superior axial image resolution of 
compared to that of conventional OCT and thus allows enhanced 
visualization of retinal layers and can perform a non invasive biopsy of 
retina
18
. 
 
This improvement is achieved by using ultra broad bandwidth light 
source instead of super luminescent diodes used in conventional OCT. A 
clinically viable UHR OCT based on femtoseconds titanium-sapphire laser 
was developed by Drexler and Fujimoto. 
 
UH OCT  is an time domain OCT which provides a axial resolution 
of 3 microns and transverse resolution of 15- 20 microns and provides with 
both A scan and B scan imaging capabilities. It utilizes femtoseconds 
sapphire laser which provides a light with 815 nm wavelength and 125 nm 
bandwidth allowing for visualization of foveal and optic disc contour and 
internal architecture of retina and choroid which the conventional OCT 
would not be able to resolve. 
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b) 3D – OPTICAL COHERENCE TOMOGRAPHY 
Is the latest technological advancement in the field of OCT which 
uses higher speeds and acquires more data in less time providing 
unparalleled view of the retinal and subretinal structures with best 
resolution. 3D-OCT is base on principle of spectral domain technology
19
. 
Conventional OCT and UHR OCT are based on time domain principle. The 
moving parts in conventional OCT are replaced by a stationary spectrometer 
in SD-OCT.  
 
Conventional OCT are depend on mechanical movements of internal 
components to measure retinal thickness hence limiting the speed and 
number of scan acquisitions. Current time domain OCT instruments 
measure on 5% of the macular area and approximate 95% of the output data.  
Hence a chance to miss very small focal lesions but SD-OCT captures a grid 
of data in macular area and is unlikely to miss these small focal lesions. 3D-
OCT uses super luminescent diode laser which produces light of 840 nm 
and 50 nm bandwidth. It provides axial resolution of 5 microns and 
transverse resolution of <20 microns.  3D-OCT can capture 256 B-scans in 
succession providing a 3 dimensional cube of details which can be viewed 
as C- scan. 
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COMPARISON OF OCT WITH STANDARD TECHNIQUES OF 
RETINAL IMAGING 
Macular thickness can be evaluated by other technique like stereo-
fundus photographs and fluorescein angiography. Retinal thickness assessed 
by stereo - fundus photography and macular hyperfluorescence on FFA 
correlates well with retinal thickness measured by OCT. 
 
However macular hyperfluorescence on FFA may not always show 
increased thickness on OCT and vice versa. Quantitative assessment of 
retinal thickness and cross sectional retinal morphology cannot be assessed 
by fundus photography and FFA. But origin of macular fluid and retinal 
microvascular abnormalities are well defined by FFA and subtle macular 
lesions are demonstrated by fundus photography which is not provided by 
OCT
20
. Thus all three imaging techniques provide complementary 
information regarding macula.  
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COMPARISON OF OCT WITH OTHER IMAGING MODALITIES 
Different criteria can be used to compare OCT with other imaging 
modalities which include depth of imaging, resolution, acquisition time, 
complexity and intrusiveness.  Imaging depth of OCT is limited to few 
millimetres less than CT, MRI or ultrasound but has greater resolution 
compared to these modalities. 
 
However confocal microscopy is better than OCT in all these aspects. 
The acquisition time in OCT is short similar to the ultrasound sufficient to 
support topographic imaging and is thus more tolerant to subject motion 
than CT OR MRI.OCT doesn’t require contact with and can be used in air 
filled organs like the ultrasound.  
 
 
 
 
 
 
 
 
 
 
COMPARISON OF OCT WITH CONFOCAL MICROSCOPY, CT, 
MRI AND ULTRASOUND
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INTRODUCTION 
 
About 4 percent of world population are estimated to be affected by 
diabetes mellitus almost half of who have some degree of diabetic 
retinopathy at any  given time
21
. In about 86% of type 1 and 33% of type 2 
DM patients in western population suffered visual loss due to diabetic 
retinopathy
22
. 
 
World health organisation reported that there has been an epidemic 
increase in type 2 DM in India .More than 90% of the patients have type 2 
DM being diagnosed usually in 4
th
 decade. However the prevalence of type 
2 DM is increasing in children and adolescent population.Diabetic 
retinopathy is becoming a important cause of visual disability.  
 
One of the leading causes of blindness worldwide is diabetic 
retinopathy. (wilkinson 1988). It is preventable. DR is basically a 
microangiopathy occurring as a complication of both the types of diabetes. 
Main structures which are affected in this condition are the precapillary 
arterioles, capillaries and venules capillaries and venules. 
 
Thus diabetic retinopathy is a microangiopathy  
36 
 
In a population based study, Chennai Urban Rural Epidemiology 
(CURES) 
23
Eye Study, in which representative sample of 26,001 individuals 
(urban Component) were included, 17.6% of 1715 diabetic patients were 
found to have diabetic retinopathy.  This study used stereo retinal 
photographs and Early Treatment Diabetic Retinopathy Study (ETDRS) 
grading to document DR in the Indian population
13
. 
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ANATOMY OF THE HUMAN RETINA 
Retina is the only part of central nervous system which can be 
visualized noninvasively as a thin delicate transparent membrane.     
 
Retina can be divided into 3 parts 
1) Optic disc 
1.5 mm well defined circular area appearing pale pink in colour. It is 
located about 3 to 4 mm nasal to the fovea. This site of optic disc sees the 
termination of all the layers of retina except the nerve fibre layer. This layer 
passes through the disc forming the optic nerve. Optic disc has a central 
depression called physiological cup which is the entry site for retinal blood 
vessels. It represents the physiological blind spot .Blind spot is not 
perceived when both the eyes are open because of overlapping of the visual 
feilds of both eyes. About 1 to 1.2 million neurons exit from the eye towards 
the brain. 
 
2) Macula lutea 
Macula lutea meaning yellow spot in latin is a 5.5mm dark area 
situated at the posterior pole. Yellow colour of macula is due to the presence 
of lutein and zeaxanthin which are the yellow xanthophyll carotenoids. 
It has an elliptical configuration and is located between the upper and lower 
arcuate   vessels and  temporal  retinal vessels.  
Macula can be further divided into 
38 
 
 
a) Fovea centralis 
It is the central depressed region of the macula.  It is about 1.85 mm 
in measurement. 
 
b) Foveola 
It measures 0.35mm from central floor of fovea and is located 2 disc 
diameter from temporal edge of the disc and 1dd   below the horizontal 
meridian. It has the highest density of cones (1, 99,000/mm
2
) which are 
narrower and elongated for maximum detection of light. Foveola contains 
only   cones and  few  muller cells. 
 
c) Umbo 
It appears as a tiny dip at the centre of foveola. It forms the foveolar 
reflex  which  is  lost in early  stages  of  macular  pathology.  
 
d) Foveal avascular zone
24 
It is present within the fovea but outside foveola and measures 
1.5mm. In this area there are no retinal capillaries and hence fovea is 
dependent solely on choriocapillaries for blood supply in this region. 
 
e) Parafoveal and perifoveal regions 
These regions lie 0.5 and 1.5 mm around the fovea. 
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3) Peripheral retina 
Includes the remaining parts of the retina outside the temporal retinal 
arteries. Anatomically this region of retina has only one layer of ganglion 
cell.  It is further divided into 
 
a) Near periphery -  Area of 1.5mm around the macula  
b) Mid periphery  -  Area of 3mm around near periphery 
c) Far periphery  - Extends 16mm from optic disc on nasal side  
and 10mm on temporal side in horizontal 
meridian 
 
d) Ora serrata - is the region where retina ends and pars plana of ciliary 
body starts. Its width is about 2.1mm temporally and 0.7 mm nasally. It 
distance from limbus is 6mm nasally and 7 mm temporally is 6-8mm.  
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Fig 3      OPTIC DISC  
 
 
Fig 4   MACULA AND PERIPHERAL RETINA 
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HISTOLOGY  
10 layers have been described in retina. From posterior to anterior 
include 
1.  Retinal pigment epithelium 
Made up of a single layer of hexagonal cells which contain pigment 
granules. This layer is firmly adherent to underlying bruch
,
s membrane and 
loosely attached to overlying photoreceptors. Sub retinal space is the 
potential space between RPE and photoreceptor layer.  
 
2.  Photoreceptor layer   
This layer consists of end organs of vision i.e photoreceptors (rods 
and cones).There are about 120 million rods and 7 million cones. Rods re 
absent in fovea. 
 
3.  External limiting membrane 
It is a fenestrated membrane formed by the junctions between cell 
membrane of photoreceptors and muller cells. It is not a true basement 
membrane. Processes of photoreceptors pass though these fenestrations.  
 
4.  Outer nuclear layer 
This layer is formed by the nuclei of photoreceptors i.e rods and 
cones. The number of rows of nuclei and thickness of this layer varies  in 
different region  of  retina. 
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5.  Outer plexiform layer 
It is made up of synapses between the rod spherules and cone pedicles 
with the dendrites of bipolar cells and processes of horizontal cells. 
 
6.  Inner nuclear layer  
This layer consists primarily of nuclei of bipolar cells. This layer is 
absent in fovea. 
 
7.  Inner plexiform layer 
Consists of synapses between the axons of first order neurons (bipolar 
cells) with dendrites of second order neurons (ganglion cells)  
 
8.  Ganglionic cell layer  
This layer is made up of bodies and nuclei of ganglion cells. Most of 
the retina has a single layer of ganglion cells, it is multilayered in macular 
region .It has 2 layers on temporal side of the disc.  
 
9.  Nerve fibre layer 
This layer is composed of unmyelinated axons of ganglion cells. 
These axons converge at optic disc and after passing through the lamina 
cribosa become myelinated. 
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10. Internal limiting membrane 
It is the innermost layer. It forms the interface between the retina and 
vitreous. 
 
BLOOD SUPPLY OF RETINA 
Retina has a dual circulation. Outer retinal layers are avascular and 
they depend on adjacent choroid for nutrition. Choroidal circulation is 
supplied by the ophthalmic artery. Choriocapillaries supply the outer one 
third of retina and the inner two thirds are supplied by central retinal artery 
which is also a branch of the ophthalmic artery. 
 
In the presence of cilioretinal artery the choroid also supplies the 
inner retina. 
 
The retinal arteries are end arteries. These arteries run outwards 
within the nerve fibre layer towards peripheral retina.  The smaller arterioles 
form 2 types of capillary systems. One is horizontal which supplies the 
nerve fibre layer .Second are the deeper branches which run into retina to 
forming one peripheral and perifoveal network and 4 peripapillary network. 
Thus all the layers of neurosensory retina are supplied by the retinal 
circulation except the layer of photoreceptor which is supplied by the 
choroid. 
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There are two capillary free zones one around arterioles and at the 
fovea which is supplied by diffusion from the choriocapillaries. All the 
capillary blood runs back to central retinal vein which ends by draining into 
ophthalmic vein or into cavernous sinus directly. 
 
Elastic tissue and smooth muscles are absent in retinal capillary wall which 
comprises of  
1. Endothelial cells forming a single layer on basement membrane. 
Tight junction  links  the  adjacent  endothelial  cells.  
2. Pericytes with multiple pseudopodial processes envelop the 
capillaries and lie external to endothelial cells. These pericytes play a 
role in auto regulation  of  micro  vascular  circulation.  
 
BLOOD RETINAL BARRIER 
Retina has two blood retinal barriers - outer and inner blood retinal 
barrier. Tight junctions between the endothelial cells of retinal capillaries 
form the inner BRB which surrounds all the retinal blood vessels where as 
the zona occludens between the RPE form the outer blood retinal barrier. 
Both these control the retinal microenvironment. Lipophillic molecules and 
very small molecules like oxygen can pass through these barriers. 
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EPIDEMIOLOGY 
The Wisconsin Epidemiologic Study of Diabetic retinopathy 
(WESDR) 
25
documented prevalence of macular edema in 11% overall 
among patients with diabetes in sothern wisconsin
n
. Prevalence was higher 
in early onset compared to patients with older onset diabetes. Strong 
association was noticed with duration and glycemic status 
 
In some diabetic populations the retinopathy prevalence including 
that of DME and CSME appears to be declining due to improved glycemic 
control of diabetes. 
 
However  the overall prevalence of DME is increasing due to     
increasing  prevalence   of   diabetes  in  industrialized nations . 
 
The WESDR determined a 10 yr rate of DME of 20% in young onset 
diabetic patient, 25.4% in older onset diabetics on insulin and 13.9% in 
older onset group not on insulin. 99% of type 1 and 60% of type 2 DM pts 
develop DR after 20 yrs. 
 
3% of patients with mild NPDR, 38% of patients with moderate to 
severe NPDR have DME. 71% of patients with PDR also develop DME. 
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RISK FACTORS AND CLINICAL ASSOCIATIONS 
1) Severity  
Severity of DR has a strong and positive correlation with macular 
edema. Since most patients with PDR do not have DME and vice versa, 
ETDRS
26
 described DR severity scale based on progression to high risk 
PDR and excluded retinal thickness per se as a additional risk factor. 
 
2) Duration  
Most important risk factor. About 50% of the patients diagnosed with 
diabetes before 30 years develop retinopathy after 10 yrs which increases to 
90% after 30yrs. 5% of type 2 DM patients have retinopathy at presentation. 
Duration of DM also has a strong relationship with prevalence and 
incidence of   macular  edema  
 
3) Poor glycemic controls. 
Second most important risk factor indentified for DME is glycemic 
control. Intensive control of glycemic status has shown to reduce the 
progression of DR, nephropathy and neuropathy as shown by the 
Epidemiology of Diabetes Intervention and control study. 
 
4) Pregnancy 
Rapid progression of retinopathy may be seen in pregnancy
27
 and the 
risk is dependent on severity of DR in 1
st
 trimester. DME has been seen to 
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worsen in pregnancy and is often associated with preexisting retinopathy 
and preeclampsia. Poor glycemic control in pregnancy is also a contributing 
factor. 
 
5) Hypertension 
United Kingdom prospective diabetic study (UKPDS) suggested that 
visual loss from macular edema can be ameliorated by having a strict 
control of systemic  hypertension  in  type 2 DM
28
. 
 
6) Nephropathy and proteinuria 
Proteinuria is positively correlated with DR however the relationship 
between renal failure and macular edema has not been clearly established. 
Studies have demonstrated an increase in macular edema occurring in 
patients who had fluid retention which improved following diuretics or 
hemodialysis. 
 
7) Dyslipidemia 
It is an independent risk factor for DME
29
. 
 
8) Intraocular  surgery  
May worsen the existing DME. Worsening of DME has been 
observed in patients who had coexisting cataract and DME and underwent 
cataract surgery before managing DME30. 
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9) Intraocular  inflammation   
 
10) Panretinal photocoagulation , Laser for PDR 
Worsening of DME has been observed in patients following PRP 
before managing  the  macular  edema. ETDRS research group suggested 
performing management of macular edema before doing a PRP in PDR 
patients with DME. 
 
11) Anemia 
Hypoxia resulting due to anaemia leads to development of 
microaneurysms and also leads to other changes in retina. 
 
12) Association  with  genes 
People with HLA DR4 and DR5 phenotype have been found to be 
having   increased   risk  of  developing  PDR 
 
13) Protective  ocular  factors  
Patients with glaucoma and high myopia have been found to be 
having lesser prevalence of DR. Also the severity of DR is reduced in these 
patients. This has been attributed to lower metabolic demands of the retina 
in these patients. 
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PATHOPHYSIOLOGY  
Diabetic retinopathy changes occur as result of combination of 
several factors which can be structural, rheological, and biochemical. 
1) Structural changes associated with diabetic retinopathy  
As the blood glucose level increases the tight junctions between the 
endothelial cells of capillaries breaks down. There is an increase in 
transcellular endocytosis resulting in fluid movement into retinal tissue from 
the vessel wall. 
 
 At some stage the fluid reuptake mechanism of retina is 
overwhelmed by this fluid accumulation resulting in retinal edema 
 
There also occurs 
1. Thickening of capillary basement membrane 
2. Pericyte loss 
3. Endothelial cell loss 
4. Dysfunction of endothelial cell 
 
2) Rheological   changes 
1. Abnormalities  of   platelet  function - Platelets become abnormally 
adhesive and aggregate more. Also the survival of platelets is reduced 
2. Abnormalities of red blood cell function - Which include reduced 
deformability and increased rouleaux formation. 
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3. Blood Protein abnormality - Fibrinogen, haptoglobulin, alfa 2 
macroglobulin levels in blood are increased. 
 
3) Biological  changes 
1) Long   standing  hyperglycemia.  
Advanced glycation end products are formed due to non enzymatic 
binding of sugars to proteins.  These end products play a crucial role in 
producing   diabetic   complications.  
 
2) Sorbitol   pathway 
Aldose reductase is an enzyme which converts glucose to sorbitol. 
Sorbitol dehydrogenase converts the sorbitol to fructose. However the 
reaction catalyzed by sorbitol dehydrogense is slower leading to building up 
of toxic levels of sorbitol which cause endothelial damage. 
 
3) Vascular  endothelial  growth  factor. 
Has been detected in diabetic retinas, It increases vascular 
permeability leading  to  DME.  
4) Protein kinase c - is emerging as another target molecule for 
pharmacological management of DME. It is selectively up regulated by 
hyperglycemia and has been found to play a role in pathogenesis of DME. 
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CLINICAL PRESENTATION 
Depending on the degree of involvement of fovea the symptoms 
experienced by   the   patients   with  DME  vary  widely.  Gradual painless 
progressive loss of vision, colour vision loss, defective night vision and dark 
adaptation is experienced by the patient 
 
DME  shows   following   features  on  clinical  examination  
a. Macular   thickening  
b. underlying   pattern   of   choroidal  vessels  gets blurred  
c. Absent  foveolar reflex  following  involvement of fovea  
d. Formation  of   intraretinal  cystic  spaces.  
e. Hard exudates which are lipoproteinaceous materials which may be 
arranged  in  a ring  like pattern called circinate retinopathy.  
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CLASSIFICATION OF DIABETIC MACULAR EDEMA. 
There are classified as  
a) Focal  type  of  macular  edema 
This type of macular edema is characterized by presence of focal 
areas of leakage due to presence of microaneursyms and capillary segments 
which are dilated. Adjacent normal retina is separated from these areas by 
hard exudates which may be arranged in the form of complete or incomplete 
rings. 
 
b) Diffuse  type  of  macular edema  
It is characterized by breakdown of the blood retinal barrier. There is 
leakage from Microaneurysm and dilated capillary bed throughout the 
posterior pole. It can have a bilaterally symmetrical presentation. 
Exacerbation and amelioration of diffuse macular edema is noted in 
association with systemic factors like renal, cardiovascular, systemic 
hypertension. 
 
C) Ischemic 
Has a variable presentation and may have a normal looking macula 
with low visual acuity. FFA shows enlargement of FAZ with foveal non 
perfusion and other capillary drop out areas in posterior pole and periphery. 
 
d) Mixed type   - Combination  of  any  of  the  above  type.  
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CLINICALLY SIGNIFICANT MACULAR EDEMA AS DEFINED BY 
ETDRS 
ETDRS
31
 defined clinically significant macular edema (CSME) as 
- Retinal thickening within 500mm of centre of the macula. 
- Exudates within 500 mm of centre of macula , if associated with  
retinal thickening ( which may be outside 500mm) 
- Retinal thickening of one disc diameter or larger any part of which is 
within one disc diameter of centre of the macula 
 
INTERNATIONAL CLINICAL DIABETIC MACULAR EDEMA 
SEVERITY SCALE classified DME as 
a)   Diabetic macular edema absent - Absence of any retinal thickening or 
hard exudates in posterior pole  
 
B) Diabetic macular edema present - Retinal thickening or hard exudates 
of some degree in posterior pole.  
 
C) Mild diabetic macular edema -   Presence of retinal thickening or hard 
exudates in posterior pole but distant from centre of macula. 
 
D) Moderate diabetic macular edema - Retinal thickening or hard 
exudates approaching centre of macula but not involving it. 
 
E) Severe diabetic macular edema  -  Hard exudates or retinal thickening 
involving centre of macula 
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Fig 4  FOCAL MACULOPATHY WITH FOCAL LEAK PATTERN 
  
 
 
Fig 5 DIFFUSE MACULOPATHY WITH DIFFUSE LEAKAGE 
 
 
 
Fig 6 ISCHEMIC MACULOPATHY WITH ENLARGED FAZ 
 
 
CLINICALLY SIGNIFICANT MACULAR EDEMA
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EVALUATION OF PATIENTS WITH CSME 
various   parameters   assessed  in  examination  include  
1) Visual acuity  
Commonly assessed with the snellens distance vision chart or log mar 
chart. 
 
2) Colour vision 
Tests used is Fransworth Munsell 100 hue test. In patients with DME 
the sensitivity of blue cones is reduced. Most   common    defect   observed  
is   blue yellow. 
 
3) Fields 
Charting of fields by tangent screen shows the presence of scotomas. 
These scotomas correspond to the retinal area of involvement. 
 
4) Slit  lamp biomicroscopy 
Allows the assessment of anterior segment pathology and cataract and 
when combined with 90 / 78 D lens provides a stereoscopic view of the 
fundus  which   is  very   useful  in  cases of CSME. 
 
5) Direct  ophthalmoscophy 
Provides higher magnification but limited field of view for 
examination. 
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6) Indirect  ophthalmoscopy 
Provides a wider field of view but lesser magnification.  Useful for 
examination of the periphery and in media opacities. 
 
7) Amsler  grid 
Allows for assessment of patients central visual field 
 
8)  Electrophysiological  tests  
a)  Electroretinography - Macular edema is associated with abnormalities 
in ERG like delay in implicit time and abnormalities of oscillatory potential 
in ascending   limb of b   wave.  
b) Electrooculography - shows abnormal Ardens Ardens ratio 
c)  Visually evoked potential - shows amplitude reduction .latency remains 
normal. 
 
9) Fundus  fluorescein  angiography   
        Plays a role in diagnosing, documenting, determining the pattern of 
leak, deciding on mode of treatment and follow up of treated patients. 
 
10) Optical  coherence  tomography  
Helps to determine the pattern of DME, retinal thickness, 
management option  and  follow  up.  
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OPTICAL COHERENCE TOMOGRAPHY IN DIABETIC 
MACULAR EDEMA 
Diabetic macular edema produces several changes at ultra structural 
levels of the retina. Topographic view obtained with two dimensional 
imaging techniques like fundus photography and FFA help in delineating 
the treatable lesions but do not provide an insight into the changes occurring 
within retinal layers which is provided by OCT.   
 
The main purpose of doing an OCT in clinically significant DME are 
- Define  the  pattern  of DME 
- Post treatment follow up of anatomical changes  
- Define indications for vitrectomy. 
 
Though slit lamp examination is very sensitive for detecting CSME 
qualitatively and FFA for the type of fluid leakage, qualitative assessment 
and quantitative measurement of retinal thickness correlates better with 
retinal dysfunction in patients of CSME as shown by numerous studies.OCT 
allows the study of subclinical retinal changes that may not be detected by 
FFA  and  slit lamp  bio microscopy.  
5 patterns of structural changes have been described in CSME in OCT. 
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1) Sponge like retinal thickening  
Appears as thickening of retina without definite cystic spaces. It is 
mostly confined to outer retinal layers as the intraretinal fluid accumulation 
caused backscattering. Hard exudates appear as areas of hyper-reflectivity 
within the retinal layers with backscattering. 
 
2) Cystoid macular edema  
OCT imaging reveals the presence of several hypo-reflective cystoid 
spaces with intervening septa located mainly in the outer retina. Size of the 
cysts may vary. In long standing cases large cysts are formed due to fusion 
of multiple smaller cysts. 
 
3) Serous  retinal   detachment 
Horizontal scan through fovea in these cases show an area of hypo 
reflectivity in sub retinal layers corresponding to areas of detachment due to 
accumulation of fluid. These areas may disappear spontaneously following 
laser. 
 
4) Taut   posterior  hyaloids 
OCT imaging in these cases shows the presence of taut posterior 
hyaloid as a hyper reflective membrane. Bio microscopic examination may 
reveal taut, shiny, glistening membrane associated with retinal striae. It may 
cause recalcitrant macular edema
n
. 
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5)  Vitreomacular  traction 
This can result in detachment of the fovea. Laser can worsen the macular 
edema in such eyes and are subjects for vitrectomy to release the traction. 
 
Both VMT and Taut posterior hyaloid may be causes of recalcitrant 
macular edema with foveal detachment. Both of these conditions can be 
diagnosed easily on OCT, even when they are subclinical. Pars plana 
vitrectomy   is   indicated   in   both  the   conditions.  
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Fig 10 SPONGY PATTERN OF CSME 
 
 
 
 
Fig 11  CYSTOID MACULAR EDEMA 
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Fig12 SEROUS RETINAL DETACHMENT 
 
 
 
Fig 13 TAUT POSTERIOR HYALOID 
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Fig 14 VITEROMACULAR TEACTION 
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BREIF OVERVIEW OF MANAGEMENT OF CSME  
PREVENTION AND CONTROL 
Incidence and progression of DR can be reduced by having optical 
metabolic control  as shown by the Diabetes Control and Complication 
Trial(DCCT) and the united kingdom prospective diabetes study(UKPDS)
32
. 
A reduction of macular edema was noticed even before laser therapy by 
strict control of risk factors like HbA1c, blood pressure, anemia, lipid 
profile and proteinuria.  Suggested Cut off value for blood pressure, LDL 
cholesterol and HbA1c are <130/80, <100mg/dl and <7% respectively. 
 
LASER TREATMENT FOR CSME 
The ETDRS study demonstrated that laser treatment reduced the risk 
of moderate visual loss (loss of 3 or more lines in snellens equivalent / 15 or 
more letters on ETDRS chart) and improved the chances of visual 
improvement   in   patients   with CSME. 
 
TREATABLE   LESIONS 
1. Focal leaks situated more than 500 microns away from the centre of 
macula causing hard exudates or retinal thickening. 
2. Focal leaks situated within 300- 500 microns from centre of macula 
causing hard exudates or retinal thickening. 
3. Areas having diffuse leakage from capillaries and microanuerysms. 
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4. Capillary avascular areas other than foveal avascular zone not treated                                            
previously. 
 
Modified ETDRS Focal/Grid laser photocoagulation of CSME. 
1. Do not treat lesions situated closer than 500 microns from the fovea 
2. Avoid intense and excessively dense laser burns 
3. Do not treat intra or pre retinal hemorrhages. 
4. Large microanuerysms that appear the main cause of leakage must be 
treated focally to the ETDRS end point of colour change( either 
whitening or darkening). 
 
TECHNIQUE  OF  FOCAL  LASER  
All the leaking microanuerysms are treated directly using a spot size 
of 50-100microns  for  duration   of  0.1  sec. 
 
TECHNIQUE  OF  GRID  LASER  
Areas of diffuse leakage without any identifiable focal areas of 
leakage are treated . Spot size used is 50-100 microns and a grid pattern of 
light intensity equally spaced burns is produced. 2 burns are placed at a 
distance of one burn width. 
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LASER TYPES USED 
Most commonly used wavelength is 514 nm and 810 nm infrared 
diode laser.   
 
MEDICAL MANAGEMENT OF CSME 
a. Intravitreal Steroids 
Steroids are beneficial in treatment due to their anti-inflammatory 
properties. Intravitreal steroids have been used in patients who had 
refractory CSME. Intravitreal triamcinolone 4mg/0.1ml alone or 
combination with laser has been studied in various therapeutic 
investigations. Side effects include cataract, iop raise, endophthalmitis and 
retinal detachment
33
. 
 
b. Intravitreal Anti Vascular Endothelial Growth Factors (VEGF) 
VEGF
34
 has inflammatory properties and is found to play a role in 
pathogenesis of DME by increasing capillary permeability. Anti VEGF 
agents help in restoring the normal permeability of blood retinal barrier. 
Bevacizumab , recombinant, humanized , monoclonal antibody against 
VEGF has been used in diffuse  type of macular edema where other 
treatment  have  failed. 
 
Dosage used is 1.25mg/0.05ml. However it has transient effect and 
has to be repeated   at   interval  of  4-6 weeks. 
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Pegatinib sodium ( Macugen) 1.3mg/0.05ml 3 injections are given at 
an interval of 6 weeks and followed for 36 weeks. Its specifically neutralises 
VEGF165. 
 
Ranibizumab is humanized, recombinant monoclonal antibody 
fragment. Injected   intravitreally   it   inhibits   all   forms of   VEGF. 
 
OTHER PHARMACOLOGICAL AGENTS UNDER STUDY 
1. Aldose reductase inhibitors- Sorbinil, Ponalrestat,Tolrestat  act by 
inhibiting aldose reductase enzyme responsible for conversion of 
glucose to Sorbitol. These agents help in slowing development of DR. 
2. Protein kinase inhibitors – Ruboxistaurin acts by inhibiting protein 
kinase c beta which plays a role in pathogenesis of CSME. 
3. Advanced glycation end products inhibitors and antioxidants 
 
SURGICAL   MANAGEMENT   OF   CSME 
CSME with evidence of taut posterior hyaloid or posterior hyaloidal 
traction are benefited by performing parsplana vitrectomy and detachment 
of posterior hyaloid. CSME not responding to laser may be benefited by 
performing vitrectomy with or without membrane peeling
35
. 
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AIM OF THE STUDY 
 
PRIMARY   OBJECTIVE 
To analyze the patterns of structural changes in clinically significant 
diabetic macular edema in patients with diabetic retinopathy by optical 
coherence tomography. 
 
SECONDARY   OBJECTIVE 
1. To quantitatively asses the central foveal retinal thickness by optical 
coherence tomography in patients with clinically significant diabetic    
macular edema. 
2. To study the profile of diabetic patients with clinically significant 
macular edema 
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MATERIALS AND METHODS 
 
METHODOLOGY  
1. Diabetic patients with recently detected clinically significant macular   
edema  by fundoscopic examination are  included in the study  
2. These patients are subjected to optical coherence tomography  
3. Patterns of macular edema and retinal thickness is studied  
 
INCLUSION   CRITERIA 
All the patients with clinically significant macular edema which was defined 
if one or more of the following criteria were met (ETDRS criteria) 
1. Retinal thickening within 500 microns of centre of macula 
2. Exudates within 500 microns of centre of the macula if associated 
with retinal   thickening 
3. Retinal thickening of one disc diameter any part of which is within 
one disc diameter of centre of the macula 
 
EXCLUSION CRITERIA 
1. Patients with macular edema due to any other cause 
2. Patients with diabetic retinopathy who had undergone any form of   
treatment – Grid /PRP 
3. Patients with diabetic nephropathy 
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4. Patients with associated hypertension  
5. Patients with media opacities 
 
EXAMINATION 
A brief history about the type, duration of diabetes, associated 
hypertension, renal problems, past history of any treatment was taken. IOP 
was measured using applanation tonometry, RBS, Urine albumin and sugar 
were estimated, Visual acuity was assessed using the Snellen’s chart.  
Anterior segment examination was done with slit lamp biomicroscopy. 
Posterior segment evaluation was done with 90D/78 D lens with slit lamp 
bio microscopy and binocular indirect ophthalmoscope. Fundus fluorescein 
angiography and optical coherence tomography was done for all patients. 
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OBSERVATION AND ANALYSIS 
 
1. AGE DISTRIBUTION 
Table 1 
Age group ( years) No of patients Percentage 
31- 40 2 8% 
41-50 5 20% 
51-60 10 50% 
61-70 6 24% 
71-80 2 8% 
 
 
As seen above in our study 20% of the patients were in 41-50 years 
age group, 40% in 51-60 years age group, and 24% in 61-70 years age 
group. Middle aged population i.e between 41- 60 years had highest 
prevalence of the  DR   which  correlates   with  the   WESDR.    
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2. SEX DISTRIBUTION  
Table 2 
Sex No of patients Percentage 
Males 15 60% 
Females 10 40% 
 
 
Males were the predominant sex affected in our study i.e 60 %. This 
observation correlates with that of Wisconsin Epidemiological study of 
diabetic retinopathy which showed a male to female ratio of 1.5:1  
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3. DURATION OF DIABETES 
Table 3 
Duration 
No of patients with 
DME 
Percentage 
<5 years 7 28% 
5-10 years 13 52% 
10-20 years 5 20% 
 
 
 
1. In our study the incidence Of DME with duration of <5 years was 28% 
2. Incidence of DME in patients with duration of 5 – 10 years was 52% 
3. Incidence of DME in patients with duration of10 – 20 years was 20% 
 
 
54. TYPE OF DIABETES 
Table 4 
Type 
Type 1 ( insulin 
dependent) 
Type 2 ( on oral HGA )
Type 2 ( on insulin   )
 
In our study 8% of patients were type 1 
were type 2 diabetics who were on oral hypoglycaemic agents and 20 % 
were type 2 diabetics on insulin therapy
2
18
Type 1 ( insulin dependent)
Type 2 ( on oral HGA )
Type 2 ( on insulin   ) 
 
No of patients Percentage
2 8% 
 18 72% 
 5 20% 
 
diabetics, 72% of patients 
. 
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5.  TYPE OF DIABETIC RETINOPATHY 
Table 5 
Type of DR  with   
CSME 
No of eyes Percentage 
Mild NPDR 10 20% 
Moderate NPDR 20 40% 
Severe NPDR 18 36% 
PDR 4 8% 
  
 
 
In our study 20% of the eyes had mild NPDR, 40% moderate NPDR, 
36% had severe NPDR and 8% had PDR 
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6.   VISUAL ACUITY 
Table 6 
Visual acuity No of eyes 
<2/60 2 
4/60 – 6/60 6 
6/36- 6/18 30 
< 6/12 12 
 
 
 
 
30 eyes in our study had a visual acuity ranging from 6/36-6/18 and 
12 eyes had VA of < 6/12. 12 eyes  had visual acuity of < 2/60  
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7. FFA PATTERNS 
Table 7 
Type No of eyes 
Focal 28 
Diffuse 12 
Mixed 8 
Ischemic 2 
 
 
 
 
 
In our study 28 eyes had focal pattern of leakage in FFA, 12 had 
diffuse pattern, 8 had mixed pattern and 2 eyes had ischemic type of 
maculopathy. 
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8. OCT TYPES 
Table 8 
Type No of eyes 
Spongy 30 
CME 12 
CME with serous detachment 6 
Vitreomacular  traction ( VMT) 1 
Taut posterior hyaloid (TPH) 1 
 
 
 
 
In our study 30 eyes had a spongy pattern in OCT, 12 had CME, 6 
had CME with serous detachment, VMT and TPH was present in one eye 
each. 
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9. RETINAL CENTRAL FOVEAL THICKNESS BY OCT 
Table 9 
Thickness in microns No of eyes 
200 - 350 16 
351-   500 16 
501-650 14 
651-800 4 
 
 
 
18 eyes in our study were found to have a thickness between 200 and 
350, 14 had a thickness between 351 – 500 and 14 had a thickness within 
the range of 501-650, 4 eyes had thickness between 651 and 800. 
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10. RETINAL CENTRAL  FOVEAL THICKNESS IN SPONGY TYPE 
OF CSME 
Table 10 
Thickness in microns No of eyes 
200 - 350 12 
351-   500 8 
501-650 6 
651-800 4 
 
 
 
 
In spongy pattern of CSME 12 eyes had  thickness in range of 200 – 
350 ,8 had thickness in range of 351 – 500 , 6 eyes had in range of 500-650 , 
4 in range of 651- 800 . 
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11. RETINAL CENTRAL FOVEAL THICKNESS IN CME 
Table 11 
Thickness in microns No of eyes 
200 - 350 2 
351-   500 3 
501-650 6 
651-800 1 
801-950 0 
 
 
 
In cystoid  pattern of CSME 2 eyes had  thickness in range of 200 – 
350 ,3 had thickness in range of 351 – 500 , 6 eyes had in range of 500-650 , 
1 in range of 651- 800 . 
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12. RETINAL  CENTRAL FOVEAL THICKNESS IN CME WITH 
SEROUS DETACHMENT 
Table 12 
Thickness in microns No of eyes 
200 - 350 2 
351-   500 4 
501-650 0 
651-800 0 
801-950 0 
 
 
 
In 6 eyes of CME with SRD pattern of CSME 4 eyes had retinal 
thickness in range of 200 – 350 and 2 had thickness in range of 351 – 500. 
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13. RETINAL CENTRAL  FOVEAL THICKNESS IN VMT 
PATTERN OF CSME 
Table 11 
Thickness in microns No of eyes 
200 - 500 0 
501-800 1 
801-1100 0 
  
 
 
In our study the vitreomacular traction pattern of CSME had a 
thickness of 554 microns 
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14. RETINAL  CENTRALFOVEAL THICKNESS IN TPH PATTERN 
OF CSME 
Table 14 
 
  
 
 
 
 
 
 
In our study the taut posterior hyaloids pattern of CSME had a 
thickness of 496 microns 
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15. CORRELATION BETWEEN DURATION OF DM AND OCT 
PATTERNS 
Table15. 
Duration Spongy CME CME with SRD VMT TPH 
<5 years 8 6 1 0 0 
5-10 years 15 5 3 1 1 
11-20 
years 
7 1 2 0 0 
 
 
 
 
In our study the spongy pattern of CSME was most common across 
the 3 groups followed by the CME and CME with serous detachment. 
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16. CORRELATION BETWEEN SEVERITY OF DR WITH OCT 
PATTERNS 
Table 16 
Severity Spongy CME CME with SRD VMT TPH 
Mild NPDR 6 3 0 1 0 
Moderate 
NPDR 
13 3 4 0 0 
Severe NPDR 8 6 1 0 1 
PDR 3 0 1 0 0 
 
 
 
In our study spongy pattern of CSME was found to be commonest in 
all types of DR. CME more common in severe NPDR patients in our group 
and CME wit SRD was commoner in moderate NPDR 
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17. CORRELATION BETWEEN FFA PATTERN AND OCT 
PATTERN OF CSME 
Table 17 
FFA pattern Spongy CME CME with SRD VMT TPH 
Focal 16 7 4 0 1 
Diffuse 6 4 1 1 0 
Mixed 6 1 1 0 0 
Ischemic 2 0 0 0 0 
 
 
 
In our study spongy, CME and CME with SRD pattern of CSME 
were more commonly associated with focal leaks on FFA. 
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18. VISUAL ACUITY AND OCT PATTERN 
TABLE 18 
Visual acuity Spongy CME CME with SRD VMT TPH 
<6/12 9 2 1 0 0 
6/18-6/36 18 7 4 0 0 
6/60-4/60 2 3 0 1 1 
<2/60 1 0 1 0 0 
 
 
 
60% of the patients with spongy pattern and CME pattern of CSME 
had visual in the range of 6/18-6/36. Visual acuity of less than 2/60 was 
observed in 2 eyes. 
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DISCUSSION 
 
our study included 50 eyes of 25 diabetic patients with CSME and 
varying degrees of severity of diabetic retinopathy.  
 
a. In our study majority of the patient’s i.e 15 patients were in the age 
group of 41 – 50 years of age. The Wisconsin Epidemiological 
study
25
 of Diabetic retinopathy revealed that middle aged population 
are more affected by DR and have a higher prevalence of DR. Our 
findings correlate with the study findings. 
b. Males were the predominant sex to be affected in our study (60 %) 
which correlates with the findings of the Wisconsin Epidemiological 
study of Diabetic retinopathy25 which suggested a male to female 
ratio of 1.5:1 
c. 28 % of the patients in our study had duration of diabetes of less than 
5 years, 52% had duration of 5 – 10 years and 20 % had a duration of 
10 -20 years.   
d. In our study 2 patients (8%) had type 1 diabetes mellitus who were on 
insulin, 18(72%) patients had type 2 DM on OHA and 5(20%) 
patients were type 2 DM patients on insulin.  
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e. CSME was associated with mild NPDR in 10 eyes (20%), moderate 
NPDR in 20 eyes (40%), and severe NPDR in 16 eyes (32%).  PDR 
was seen in   only   4 eyes (8%)  in   our  study. 
f. Visual acuity of < 6/12 was seen in 12 eyes (24%), Visual acuity 
between 6/18 -6/36 in 29 eyes (58%), 7 eyes (14%) had VA between 
6/60 -4/60,  2 eyes (4%)  had  VA  of  less than 2/60. 
g. On fundus fluorescein angiography focal pattern of diabetic 
maculopathy was noted in 28 eyes(56%), diffuse pattern of diabetic 
maculopathy in 12 eyes(24%) ,mixed pattern of diabetic maculopathy 
in 8eyes(16%)  and  2  eyes(4%)  had  ischemic type. 
h. On performing OCT spongy pattern of CSME was noted in 30 eyes 
(60%), cystoid pattern in 12 eyes (24%), cystoid pattern with serous 
retinal detachment was noted in 6 eyes (12%), Vitreomacular traction 
and taut posterior hyaloids was identified in one eye each.  The 
spongy pattern of diabetic macular edema was found to be the 
predominant form
36
 of structural type of DME in patients of our study 
group. This correlates with the study conducted  and  presented in 
AIOS by Anush goyal37 et al. 
i. In our study 16 eyes (32%) had central foveal thickness in the range 
of 200-350, 16 eyes (32%) had thickness in the range of 351-500, 14 
eyes (28%) had central  foveal thickness in the   range of 501-650, 
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and 4 eyes (8%) had central foveal thickness in range of 651-800 
microns. 
j. In the group with spongy pattern of CSME 12 eyes (40%) had a  
central foveal thickness in range of 200 -350, 8 eyes (27%) in range 
of 351-500, 6eyes (20%) in the range of 501 – 650, 4 eyes (13%) in 
651-800 micron range. 
k. In the group with cystoid pattern of CSME, 2 eyes(17%) had a  
central foveal thickness in range of 200- 350 microns, 3 eyes(25%) in 
351-500 range, 6eyes(50%) in 501-650 range and 1(8%) in 651-800 
micron thickness range.  
l. 2 eyes (34%) in group of cystoid with serous detachment pattern had  
central foveal thickness in range of 200 -350 microns and 4 eyes 
(66%) in range  of  351-500  microns.  
m. One eye with VMT pattern had a central  foveal thickness of 554 
microns and one eye with taut posterior hyaloids had foveal thickness 
of 496 microns. 
n. Mean central foveal thickness in normal individual is 182 +/- 23 
microns24,1. In our study group the mean central  foveal thickness was 
454 +/- 138 microns. This difference in retinal thickness between 
normal individual and patient with clinically significant DME was 
found to be highly significant (p<0.002). 
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o. Spongy pattern of CSME was found to be the commonest pattern in 
all groups of patients who were classified depending on duration of 
DM. 
 
Eyes with DM of <5 years had spongy pattern in 8eyes (54%). CME 
in 6 eyes (40%) and 1 eye (6%) had CME with SRD.  
 
Eyes with DM of 5 – 10 year duration had spongy type in 15 eyes 
(60%), CME in 5eyes (20%), CME with SRD in 3 eyes (12%) and 
VMT and TPH in one eye each. In eyes with DM of >10 years 
spongy type was seen in 7 eyes (70%), CME in 2 eyes (20%), and one 
eye (10%) had CME with SRD. 
 
p. Mild NPDR was seen in 10 eyes, 6 eyes (60%) were of spongy 
pattern and3 eyes (30%) of CME pattern. Moderate NPDR was seen 
in 20 eyes, 13 eyes (65%) of spongy pattern, 3 eyes (15%) and 4 eyes 
(20%) of CME with SRD. Severe NPDR was present in 16 eyes, 8 
eyes (50%) were of spongy pattern, 6 eyes (38%) of CME pattern and 
1 eye (6%) each of CME with SRD and TPH. PDR was seen in 4 
eyes, 3 were of spongy pattern (75%) and one eye was of CME with 
SRD.  
q. Focal pattern of leakage on FFA was predominantly associated with 
spongy type of CSME pattern (54%).  28 eyes had focal leakage out 
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of which 16 (58%) were spongy, 7(25%) were CME,4 (14%) were 
CME with SRD and one eye had TPH.12eyes had diffuse pattern out 
of which 6 ( 50%) were spongy pattern , 4 (34%) were CME pattern , 
one eye(8%) each were  of CME with SRD and VMT. Mixed leakage 
was seen in 8 eyes, 6 (76%) was of spongy pattern and one each of 
CME and CME with SRD.   
Two eyes had ischemic pattern both of which had spongy pattern in 
OCT. 
r. 11 eyes had visual acuity of <6/12, 9 were associated with spongy, 2 
with CME and 1 eye had CME with SRD. 29 eyes had visual acuity 
between 6/18-6/36, 18 had spongy pattern (62%), 7 had CME (24%), 
4 had CME with SRD (14%).7 eyes had visual acuity between 6/60-
4/60, 2 had spongy pattern (28%), 3 had CME (42%) and one each 
had VMT and TPH. Visual acuity of less than 2/60 was seen in 2 
eyes, one had spongy pattern and other had CME with SRD.  
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CONCLUSION 
 
In our study 50 eyes of 25 patients was studied. 
 
On OCT spongy pattern of CSME was found to be the commonest 
pattern (60%) followed by CME (24%), CME with SRD (12%). VMT and 
TPH was least common pattern (2%). 
 
Spongy pattern had an average central foveal thickness of 412 
microns, CME pattern had average central  foveal thickness of 504 microns 
and CME with SRD had average central foveal thickness of 409 microns. 
Average central foveal thickness in all the eyes of CSME was 454+/-136 
microns which was statistically significant when compare to  central foveal 
thickness of   normal  individuals. 
 
Moderate NPDR was commonest type of DR in eyes with spongy 
(41%) and CME with SRD pattern of CSME (66%). Severe NPDR was the 
commonest type of DR in cystoid pattern (50%) in our study group.  
 
Focal maculopathy was the commonest FFA pattern associated with 
spongy (54%), CME (59%) and CME with SRD (66%). Majority of eyes 
with spongy (60%), CME (58%) and CME with SRD (66%) had visual 
acuity between 6/18-6/36. Two eyes had visual acuity less than 2/60. 
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Middle aged group i.e between 41- 60 years is found to be having the 
greatest incidence of diabetic maculopathy. Males were found to be affected 
predominantly. Incidence of diabetic retinopathy was found be higher in 
patients who had diabetes for a longer duration. Majority of the patients in 
our  study  group were type 1 diabetics on OHA.  
 
OCT greatly facilitates the study of retinal foveal anatomy and 
thickness by providing a high resolution cross sectional images of the retina. 
Also subtle macular edema that may be difficult to detect on slit lamp 
examination can be easily detected by OCT.  FFA helped to determine the 
specific pattern of leakage which helps in determining the type of laser 
treatment.  
 
Determining the type of CSME and retinal thickness by OCT helps in 
determining the mode of treatment and treatment response in these patients. 
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PROFORMA 
 
Serial no 
Name 
Age 
Sex 
OP No 
Occupation 
History 
Complaints 
1. Defective vision 
2. Pain in the eye 
3. Field defects 
 
Past history 
1. Diabetes        -  Type, duration, on OHA/inj insulin 
2. Hypertension – Duration, medication 
 
Family history 
Systemic examination 
Pulse rate 
Blood pressure 
RBS 
Urine alb and sugar 
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Ocular examination 
RE   LE 
Visual acuity     - 
Conjunctiva      - 
Cornea      - 
Anterior chamber     - 
Iris       - 
Pupils      -  
Lens       - 
Tension (applanation tonometry)  -  
Fields by tangent screen    -  
Colour vision (Ishihara chart)    - 
 
Fundus examination                                
By direct ophthalmoscopy   - 
By indirect ophthalmoscopy   - 
Fundus fluorescein angiography  : Type of leak 
Optical coherence tomography   : Type of CSME 
Macular thickness            
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KEY TO MASTER CHART 
 
VA  - Visual acuity 
NPDR - Non proliferative diabetic retinopathy 
PDR  - Proliferative diabetic retinopathy 
CSME - Clinically significant macular edema 
FFA  - Fundus fluorescein angiography 
OCT  - Optical coherence tomography 
RE  - Right eye 
LE  - Left eye 
VMT  - Vitreomacular traction 
TPH  - Taut posterior hyaloids 
CME  - Cystoid macular edema 
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MASTER CHART 
 
Name 
 
Age 
Sex 
Duration 
of DM in 
years 
Type of 
DM 
Diagnosis  visual acuity FFA pattern Oct pattren 
Central 
foveal 
thickness 
in 
microns 
RE LE RE LE RE LE RE LE RE LE 
                              
Vargees 43 F 2 
Type 2 
OHA 
Moderate 
NPDR/CSME Mild NPDR/CSME 
6/36 PH 
6/24 
6/36 
PH6/12 Mixed Focal Spongy Spongy 480 456 
Ramaswamy 56 M 7 
Type 2 
OHA 
PDR/CSME 
Moderate 
NPDR/CSME 
6/12 PH 
6/9 2/60 NIP Focal Focal Spongy 
Cysoid with 
SRD 226 464 
Gopi 45 M 3 
Type 2 
OHA 
Mild 
NPDR/CSME 
Moderate 
NPDR/CSME 
6/24 PH 
6/18 
4/60 PH 
6/60 Diffuse Ischemic Spongy Spongy 512 210 
Parvathi 54 F 4 
Type 2 
OHA 
Moderate 
NPDR/CSME 
Severe 
NPDR/CSME 
6/9 PH 
6/6 
6/36 PH 
6/24 Focal Focal Spongy 
Cysoid with 
SRD 254 357 
Prabhakar 41 M 1 
Type 2 
OHA 
Severe 
NPDR/CSME Mild NPDR/CSME 6/24 NIP 6/18   NIP Diffuse Diffuse Cystoid Cystoid 541 287 
Raja 60 M 9 
Type2  
insulin 
Severe 
NPDR/CSME PDR/CSME 6/9 NIP 6/24 NIP Focal Focal Cystoid Spongy 265 411 
Antonioammal 51 F 3 
Type 2 
OHA 
Severe 
NPDR/CSME Mild NPDR/CSME 2/60 NIP 
6/36 PH 
6/24 Ischemic Mixed Spongy Spongy 298 540 
Pencilamma 42 F 4 
Type 2 
OHA 
Mild 
NPDR/CSME 
Moderate 
NPDR/CSME 6/24 NIP 6/12 NIP Diffuse Focal Spongy 
Cysoid with 
SRD 540 448 
Muthulaxmi 57 F 6 
Type 2 
OHA 
Severe 
NPDR/CSME 
Severe 
NPDR/CSME 6/12 NIP 6/24 NIP Focal Focal Spongy Spongy 563 268 
Radhakrishnan 63 M 9 
Type2  
insulin 
PDR/CSME 
Severe 
NPDR/CSME 6/36 NIP 
6/12 PH 
6/9 Mixed Focal Spongy Cystoid 589 484 
Pandian 55 M 7 
Type 2 
OHA 
Mild 
NPDR/CSME 
Moderate 
NPDR/CSME 6/24 NIP 6/36 NIP Focal Diffuse TPH Spongy 496 554 
Kamalamma 65 F 8 
Type 2 
OHA 
Severe 
NPDR/CSME PDR/CSME 
6/12 PH 
6/9 6/9   NIP Focal Mixed Spongy 
Cysoid with 
SRD 512 326 
Arumugam 45 M 4 
Type 2 
OHA 
Mild 
NPDR/CSME Mild NPDR/CSME 
6/36 
PH6/12 
6/36 PH 
6/24 Diffuse Focal Cystoid Spongy 536 482 
Prema 69 F 9 
Type2  
insulin 
Moderate 
NPDR/CSME 
Moderate 
NPDR/CSME 
6/24 PH 
6/12 
6/36  PH 
6/18 Focal Diffuse Spongy Spongy 214 461 
Srinivasan 57 M 4 
Type 2 
OHA 
Mild 
NPDR/CSME 
Moderate 
NPDR/CSME 6/12 NIP 
6/36 PH 
6/24 Focal Focal Cystoid Cystoid 593 547 
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Chennaiya 67 M 8 
Type 2 
OHA 
Severe 
NPDR/CSME 
Moderate 
NPDR/CSME 
6/12 PH 
6/9 
6/24 PH 
6/18 Focal Diffuse Spongy Spongy 524 214 
Vallikannu 36 F 10 Type 1 
Moderate 
NPDR/CSME 
Severe 
NPDR/CSME 6/9 NIP 6/18 NIP Diffuse Focal Spongy Cystoid 350 580 
Karunakaran 39 M 12 Type 1 
Severe 
NPDR/CSME 
Moderate 
NPDR/CSME 6/12 NIP 
6/12 PH 
6/9 Focal Focal Spongy Spongy 264 291 
Shanti 63 F 6 
Type2  
insulin 
Severe 
NPDR/CSME 
Moderate 
NPDR/CSME 5/60 NIP 6/24NIP Diffuse Focal VMT Spongy 554 394 
Gubendran 68 M 9 
Type2  
insulin 
Severe 
NPDR/CSME 
Severe 
NPDR/CSME 6/24NIP 
4/60 
PH6/60 Focal Focal Spongy Cystoid 246 694 
Gowri 59 F 8 
Type 2 
OHA 
Moderate 
NPDR/CSME 
Severe 
NPDR/CSME 
6/36 
PH6/18 5/60 NIP Focal Diffuse Cystoid Cystoid 451 490 
Govindraj 72 M 14 
Type2  
insulin 
Moderate 
NPDR/CSME 
Moderate 
NPDR/CSME 
6/36 
PH6/12 6/36NIP Diffuse Mixed 
Cysoid with 
SRD Spongy 454 415 
Perumal 74 M 16 
Type2  
insulin 
Severe 
NPDR/CSME 
Moderate 
NPDR/CSME 6/9NIP 
6/36 PH 
6/18 Focal Mixed Spongy Spongy 332 424 
Saraswati 53 F 7 
Type 2 
OHA 
Moderate 
NPDR/CSME Mild NPDR/CSME 
6/12 PH 
6/9 
6/24 PH 
6/18 Focal Focal 
Cysoid with 
SRD Spongy 289 280 
Balakrishnan 58 M 7 
Type 2 
OHA 
Moderate 
NPDR/CSME 
Moderate 
NPDR/CSME 
4/60 PH 
6/60 5/60 NIP Mixed Mixed Spongy Cystoid 756 487 
  
